BIT Capital’s Neumora Therapeutics NMRA Stock Holding History

BIT Capital’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-91,656	Closed	-$1.26M	–	121
2024 Q1	$1.26M	Buy	+91,656	New	+$1.48M	0.09%	83

Other funds holding NMRA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BIT Capital's NMRA Position: Q2 2024 in Review

BIT Capital sold out of Neumora Therapeutics (NMRA) in Q2 2024, closing a stake of 91,656 shares — an estimated $1.26M sold.

BIT Capital first reported a position in NMRA in Q1 2024 and held it in 1 quarter. The position peaked at $1.26M in Q1 2024. 93 funds tracked by Wall St. Rank hold NMRA as of Q2 2024.

BIT Capital reported no remaining Neumora Therapeutics position as of Q2 2024 after selling out during the quarter.
BIT Capital sold 91,656 Neumora Therapeutics shares in Q2 2024, an estimated $1.26M.
BIT Capital first reported a position in Neumora Therapeutics in Q1 2024 and held it in 1 quarter.
BIT Capital's Neumora Therapeutics position peaked at $1.26M in Q1 2024.
93 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2024.

Based on BIT Capital's 13F filing for Q2 2024, filed 12 Feb 2025.